Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

OLMA Olema Pharmaceuticals Inc

14,99

3,23 (27,47%)

Zuletzt aktualisiert: 19:13:47

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Olema Pharmaceuticals Charts.

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Olema Pharmaceuticals Charts.

News Olema Pharmaceuticals Inc

Form 144 - Report of proposed sale of securities
Montag 3 Juni 2024 (23 Stunden vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 31 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 28 Mai 2024 (7 Tage vor) • Edgar (US Regulatory)

Olema Oncology to Participate in Upcoming Investor Conferences in June
Dienstag 28 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 15 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
Mittwoch 15 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mittwoch 8 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
Mittwoch 8 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 6 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Weitere Olema Pharmaceuticals Inc News-Artikel

IN XTK 2 EURGOV

NLBNPIT1VWU9 20991231 15...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen